These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
515 related items for PubMed ID: 1967523
1. Use of beta 2-microglobulin level and CD4 lymphocyte count to predict development of acquired immunodeficiency syndrome in persons with human immunodeficiency virus infection. Anderson RE, Lang W, Shiboski S, Royce R, Jewell N, Winkelstein W. Arch Intern Med; 1990 Jan; 150(1):73-7. PubMed ID: 1967523 [Abstract] [Full Text] [Related]
2. Improvement of the predictive value of CD4+ lymphocyte count by beta 2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate. The Multicentre Cohort Study Group. Schwartländer B, Bek B, Skarabis H, Koch J, Burkowitz J, Koch MA. AIDS; 1993 Jun; 7(6):813-21. PubMed ID: 8103341 [Abstract] [Full Text] [Related]
3. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I. AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100 [Abstract] [Full Text] [Related]
4. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II. AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101 [Abstract] [Full Text] [Related]
5. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. Fahey JL, Taylor JM, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV. N Engl J Med; 1990 Jan 18; 322(3):166-72. PubMed ID: 1967191 [Abstract] [Full Text] [Related]
6. Serum beta 2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis. Hofmann B, Wang YX, Cumberland WG, Detels R, Bozorgmehri M, Fahey JL. AIDS; 1990 Mar 18; 4(3):207-14. PubMed ID: 1972020 [Abstract] [Full Text] [Related]
7. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients]. Vial PA, Ferreccio C, Abarca K, Ortiz E, Noriega M, Pérez C, Labarca J, Torres M, Ferrés M, González C, Acuña G. Rev Med Chil; 1996 May 18; 124(5):525-35. PubMed ID: 9035503 [Abstract] [Full Text] [Related]
10. The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels. Sheppard HW, Lang W, Ascher MS, Vittinghoff E, Winkelstein W. AIDS; 1993 Sep 18; 7(9):1159-66. PubMed ID: 8105806 [Abstract] [Full Text] [Related]
11. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection]. Antón F, Labarga P, Pinilla J, Soto MJ, Leoz A, del Cura J, Borque L, Milazzo A. Enferm Infecc Microbiol Clin; 1993 Sep 18; 11(7):373-7. PubMed ID: 8104488 [Abstract] [Full Text] [Related]
12. [The prognostic value of different patterns of change in the CD4 lymphocyte counts in 420 symptom-free HIV-1-infected persons]. Günthard H, Opravil M, Ledergerber B, Olsson K, Vogt M, Fierz W, Lüthy R. Dtsch Med Wochenschr; 1993 May 21; 118(20):737-45. PubMed ID: 8099005 [Abstract] [Full Text] [Related]
13. Use of monitored CD4 cell counts: predictions of the AIDS epidemic in Scotland: CD4 Collaborative Group. AIDS; 1992 Feb 21; 6(2):213-22. PubMed ID: 1348418 [Abstract] [Full Text] [Related]
14. Distribution of CD4+ T lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses. The Adult and Adolescent Spectrum of HIV Disease Project Group. Hanson DL, Chu SY, Farizo KM, Ward JW. Arch Intern Med; 1995 Jul 24; 155(14):1537-42. PubMed ID: 7605156 [Abstract] [Full Text] [Related]
15. C-reactive protein is a marker for human immunodeficiency virus disease progression. Lau B, Sharrett AR, Kingsley LA, Post W, Palella FJ, Visscher B, Gange SJ. Arch Intern Med; 2006 Jan 09; 166(1):64-70. PubMed ID: 16401812 [Abstract] [Full Text] [Related]
16. Direct comparison of the relationship between clinical outcome and change in CD4+ lymphocytes in human immunodeficiency virus-positive homosexual men and injecting drug users. Margolick JB, Muñoz A, Vlahov D, Astemborski J, Solomon L, He XY, Nelson KE, Saah AJ. Arch Intern Med; 1994 Apr 25; 154(8):869-75. PubMed ID: 7908795 [Abstract] [Full Text] [Related]
17. [Serum adenosine deaminase in human immunodeficiency virus infection. Its relationship with CD4+ lymphocytes and beta 2-microglobulin]. Iñigo MA, Ruiz López de Tejada M, Torres-Tortosa M, Sánchez-Porto A, Ugarte I, García de Lomas E, Morán Nestares A. Med Clin (Barc); 1992 Dec 12; 99(20):766-8. PubMed ID: 1361013 [Abstract] [Full Text] [Related]
18. CD4 surveillance in Scotland: perspectives on severe HIV-related immunodeficiency. CD4 Collaborative Group. AIDS; 1997 Oct 12; 11(12):1509-17. PubMed ID: 9342074 [Abstract] [Full Text] [Related]
19. Survival in a cohort of human immunodeficiency virus-infected tuberculosis patients in New York City. Implications for the expansion of the AIDS case definition. Stoneburner R, Laroche E, Prevots R, Singh T, Blum S, Terry P, Reatrice S, Adler J. Arch Intern Med; 1992 Oct 12; 152(10):2033-7. PubMed ID: 1358042 [Abstract] [Full Text] [Related]
20. [Discriminative value for AIDS case of erythrocyte sedimentation rate, immunoglobulins IgA and IgM, and beta 2-microglobulin in combination with the CD4+ lymphocyte count]. Pérez de Oteyza C, Menéndez Martínez MA, Muro García R, Pérez Aznar C, Barberán López J. An Med Interna; 1998 Aug 12; 15(8):411-4. PubMed ID: 9780421 [Abstract] [Full Text] [Related] Page: [Next] [New Search]